Syndrome Differentiation in the Management of Chronic Stable Coronary Artery Disease (SCAD) to Improve Quality
NCT ID: NCT03018769
Last Updated: 2017-01-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
2000 participants
OBSERVATIONAL
2016-12-31
2017-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1.3 To formulate a syndrome differentiation determined medicine plan based on the improvement in the quality of life on chronic stable CAD patients.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Integrated Treatment by Traditional Chinese and Western Medicine in Reducing Cardiovascular Events
NCT01715376
Effect of Chinese Traditional Medicine for Post Revascularization Treatment of Coronary Artery Disease
NCT00965471
Cohort Study on Treatment of Cardiovascular Diseases With Traditional Chinese Medicine
NCT05309343
Studies of Traditional Chinese Medicine Clinical Efficacy Evaluation Index
NCT01502943
Study of Herbal Formula Corresponding to Syndrome in Treating Post Percutaneous Coronary Intervention (PCI) Patients With Coronary Heart Disease (CHD)
NCT00817024
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Traditional Chinese medicine (TCM) has two thousand years of history in managing CAD and has its advantages in improving quality of life. Using scientific method to evaluate, demonstrate and conclude the clinical curative effect of TCM is an extremely important task for both TCM and Chinese and western integrative medicine win the treatment of CAD. Recent researches mainly focus on certain types or some certain pathological and physiological stages of CAD, worse still, different areas experts have their own experiences and opinions with the treatment. There is a lack of unified syndrome differentiation and prescriptions plan for the chronic stable CAD and not enough attention has been paid to TCM despite it having many advantages in improving quality of life in these patients. Considering all the above, this research studied past syndromes research results and real clinical effective chronic SCAD cases. Cases were analysed and explored, effective cases were filtered, syndrome differentiation of the prescriptions was refined, thus build a TCM diagnosis and treatment information database.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
chronic SCAD
Chinese Herb
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Chinese Herb
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* diagnose as chronic SCAD at first visit
* heart function classification between II\~III Canada classification(CCS)
* Be willing to accept Chinese herbal decoction
* sign an informed consent
Exclusion Criteria
* have such diseases as follow: a.poorly controlled blood pressure even taken medicine(systolic pressure≥180mmHg, diastolic pressure≥100mmHg); - severe arrhythmia(atrial fibrillation with rapid ventricular response, atrial flutter, paroxysmal ventricular tachycardia, etc); c.pulmonary heart disease, rheumatic heart disease, myocarditis, cardiomyopathy, aortic dissection, pulmonary embolism.
* hyperthyreosis, cervical spondylosis, gallbladder-cardiac syndrome, gastroesophageal reflux, esophageal hiatal hernia, neurosis, climacteric syndrome and other diseases which would cause chest pain.
* alanine transaminase(ALT) or serum creatinine(Scr) more than twice the normal reference value.
* hemoglobin(Hb)\<100g/L or have severe hematological system disease.
* malignant tumor.
* pregnant, lactating women or other women have reproductive requirement.
* psychosis or cognition impairment person.
* taken chinese medicine decoction in recent two weeks.
* not take part in any other clinical trail.
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bi Yingfei
doctor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine
Anhui, , China
Beijing Hospital of Traditional Chinese Medicine
Beijing, , China
Dongfang Hospital of Beijing University of Chinese Medicine
Beijing, , China
Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine
Beijing, , China
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Beijing, , China
the third Affiliated to Beijing University of Chinese Medicine
Beijing, , China
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Beijing, , China
Affiliated Hospital of Changchun University of Traditional Chinese Medicine
Changchun, , China
Affiliated Hospital of Gansu University of Chinese Medicine
Gansu, , China
Guangdong Provincial Hospital of Chinese Medicine
Guangdong, , China
Guangdong Second Troditional Chinese Medicine Hospital
Guangdong, , China
First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine
Guangzhou, , China
Heilongjiang Provincial Hospital of traditional Chinese Medicine
Heilongjiang, , China
Henan Province Hospital of TCM
Henan, , China
The First Affiliated Hospital of Henan University of TCM
Henan, , China
Affiliated Hospital of Hunan Academy of Chinese Medicine
Hunan, , China
The First Hospital of Hunan University of Chinese Medicine
Hunan, , China
The Second Affiliated Traditional hospital of Hunan University of Traditional Chinese Medicine
Hunan, , China
Jiangsu Province Hospital of TCM
Jiangsu, , China
Jiangxi Provincial Hospital of Chinese Medicine
Jiangxi, , China
Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
Liaoning, , China
The Second Affiliated Hospital of Liaoning University of traditional Chinese Medicine
Liaoning, , China
Shandong Province Hospital of Traditional Chinese Medicine
Shandong, , China
Shanxi Hospital of Traditional Chinese Medicine
Shanxi, , China
Shanxi Province Hospital of Traditional Chinese Medicine
Shanxi, , China
The Affiliated Hospital to Shanxi University of Traditional Chinese Medicine
Shanxi, , China
The Second Affiliated Hospital of Shanxi University of Traditional Chinese Medcine
Shanxi, , China
Shijiazhuang Traditional Chinese Medicine Hospita
Shijiazhuang, , China
First Teaching Hospital of Tianjin University of TCM
Tianjin, , China
Second Affiliated Hospital of Tianjin University of TCM
Tianjin, , China
Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital
Tianjin, , China
Traditional Chinese Medicine Hospital of Xinjiang Uygur Autonomous Region
Xinjiang, , China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FirstTeachingHTianjinUTCM
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.